EyePoint Pharmaceuticals, Inc.
EyePoint Pharmaceuticals, Inc. (EYPT) Insider Trading
Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.
SEC EDGAR · FMP · EYPT · as of Jun 8, 2026
Activity summary
Buy transactions
1
P-Purchase only
Sell transactions
9
12 Months
Buy/Sell ratio
0.11
Buy/Sell (by trades)
Overall sentiment
EyePoint Pharmaceuticals, Inc. insiders have been primarily selling shares over the past 12 Months. Selling activity is often driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment toward the company.
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only
As of Jun 8, 2026
EYPT insider buying and selling by quarter
EYPT insider selling · EYPT insider buying stocks · quarterly insider activity
Mobile shows last 4Q · Desktop shows full 8Q
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters
As of Jun 8, 2026
Active insiders
Most active in past 12 months · EYPT ceo insider trading
Showing all insiders · Click a card to filter the transactions table below
▸ Aggregated from reportingName · top 5 by trade count (12M) · no extra API
Recent insider transactions
EYPT executive sell shares · EYPT board member insider trading · EYPT insider trading SEC filing
Scroll horizontally to see all columns
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| May 25, 2026 | Elston George CFO | Option | 7,500 | — | Form 4 |
| May 25, 2026 | Elston George CFO | Other | 3,627 | $47K | Form 4 |
| Apr 17, 2026 | Ribeiro Ramiro Chief Medical Officer | Option | 2,437 | $20K | Form 4 |
| Apr 17, 2026 | Ribeiro Ramiro Chief Medical Officer | Sale | 2,437 | $37K | Form 4 |
| Mar 23, 2026 | Duker Jay S. President and CEO · Director | Other | 76,766 | $1.01M⚡ | Form 4 |
| Mar 23, 2026 | Duker Jay S. President and CEO · Director | Other | 76,766 | $1.01M⚡ | Form 4 |
| Mar 16, 2026 | Duker Jay S. President and CEO · Director | Purchase | 1,500 | $20K | Form 4 |
| Mar 2, 2026 | Elston George CFO | Gift | 5,000 | — | Form 4 |
| Mar 2, 2026 | Elston George CFO | Gift | 5,000 | — | Form 4 |
| Mar 4, 2026 | Ribeiro Ramiro Chief Medical Officer | Option | 2,438 | $20K | Form 4 |
| Mar 4, 2026 | Ribeiro Ramiro Chief Medical Officer | Sale | 2,438 | $44K | Form 4 |
| Feb 17, 2026 | Ribeiro Ramiro Chief Medical Officer | Option | 2,437 | $20K | Form 4 |
| Feb 17, 2026 | Ribeiro Ramiro Chief Medical Officer | Sale | 2,437 | $37K | Form 4 |
| Jan 6, 2026 | Lurker Nancy Director | Option | 75,133 | — | Form 4 |
| Jan 6, 2026 | Duker Jay S. President and CEO · Director | Option | 20,793 | — | Form 4 |
| Jan 6, 2026 | Duker Jay S. President and CEO · Director | Other | 10,054 | $170K | Form 4 |
| Jan 6, 2026 | Elston George CFO | Option | 15,285 | — | Form 4 |
| Jan 6, 2026 | Elston George CFO | Other | 4,487 | $76K | Form 4 |
| Jan 5, 2026 | Ribeiro Ramiro Chief Medical Officer | Option | 29,250 | $242K | Form 4 |
| Jan 5, 2026 | Ribeiro Ramiro Chief Medical Officer | Sale | 42,544 | $727K | Form 4 |
| Jan 3, 2026 | Ribeiro Ramiro Chief Medical Officer | Option | 19,667 | — | Form 4 |
| Jan 3, 2026 | Ribeiro Ramiro Chief Medical Officer | Other | 6,373 | $111K | Form 4 |
| Jan 5, 2026 | Duker Jay S. President and CEO · Director | Option | 30,000 | — | Form 4 |
| Jan 3, 2026 | Duker Jay S. President and CEO · Director | Option | 65,000 | — | Form 4 |
| Jan 5, 2026 | Duker Jay S. President and CEO · Director | Other | 14,505 | $253K | Form 4 |
Ribeiro Ramiro
Chief Medical Officer
Date
Apr 17
Shares
2,437
Price
$8.26
Value
$20K
Ribeiro Ramiro
Chief Medical Officer
Date
Apr 17
Shares
2,437
Price
$15.00
Value
$37K
Duker Jay S.
President and CEO · Director
Date
Mar 23
Shares
76,766
Price
$13.11
Value
$1.01M ⚡
Duker Jay S.
President and CEO · Director
Date
Mar 23
Shares
76,766
Price
$13.11
Value
$1.01M ⚡
Duker Jay S.
President and CEO · Director
Date
Mar 16
Shares
1,500
Price
$13.15
Value
$20K
Ribeiro Ramiro
Chief Medical Officer
Date
Mar 4
Shares
2,438
Price
$8.26
Value
$20K
Ribeiro Ramiro
Chief Medical Officer
Date
Mar 4
Shares
2,438
Price
$17.87
Value
$44K
Ribeiro Ramiro
Chief Medical Officer
Date
Feb 17
Shares
2,437
Price
$8.26
Value
$20K
Ribeiro Ramiro
Chief Medical Officer
Date
Feb 17
Shares
2,437
Price
$15.00
Value
$37K
Duker Jay S.
President and CEO · Director
Date
Jan 6
Shares
20,793
Price
—
Value
—
Duker Jay S.
President and CEO · Director
Date
Jan 6
Shares
10,054
Price
$16.86
Value
$170K
Ribeiro Ramiro
Chief Medical Officer
Date
Jan 5
Shares
29,250
Price
$8.26
Value
$242K
Ribeiro Ramiro
Chief Medical Officer
Date
Jan 5
Shares
42,544
Price
$17.10
Value
$727K
Ribeiro Ramiro
Chief Medical Officer
Date
Jan 3
Shares
6,373
Price
$17.48
Value
$111K
Duker Jay S.
President and CEO · Director
Date
Jan 5
Shares
30,000
Price
—
Value
—
Duker Jay S.
President and CEO · Director
Date
Jan 3
Shares
65,000
Price
—
Value
—
Duker Jay S.
President and CEO · Director
Date
Jan 5
Shares
14,505
Price
$17.43
Value
$253K
⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar
▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —
About EYPT insider trading
EYPT insider trades
EyePoint Pharmaceuticals, Inc. (EYPT) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including Elston George (CFO), Duker Jay S. (President and CEO · Director), Ribeiro Ramiro (Chief Medical Officer). Over the past 12 months, 5 insiders have filed transactions with the SEC. EYPT insiders have been primarily selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.
For EyePoint Pharmaceuticals, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →
Frequently asked questions
EYPT insider trading · 5 questionsThe insiders of EyePoint Pharmaceuticals, Inc. (EYPT) include executives and directors such as Elston George (CFO), Duker Jay S. (President and CEO · Director), Ribeiro Ramiro (Chief Medical Officer), among others. Over the past 12 months, 5 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.
▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 8, 2026